J Cancer 2017; 8(16):3212-3225. doi:10.7150/jca.19794 This issue

Research Paper

Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions

Yongzhi Yang1,2, Peng Junjie1,2, Cai Sanjun1,2, Yanlei Ma1,2✉

1. Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Yang Y, Junjie P, Sanjun C, Ma Y. Long non-coding RNAs in Colorectal Cancer: Progression and Future Directions. J Cancer 2017; 8(16):3212-3225. doi:10.7150/jca.19794. Available from https://www.jcancer.org/v08p3212.htm

File import instruction


Identification of the colorectal adenoma-carcinoma sequence with its corresponding genetic and epigenetic alterations has significantly increased our knowledge of the etiopathogenesis of colorectal cancer (CRC). However, the molecular mechanisms of colorectal carcinogenesis and metastasis haven't been clearly elucidated. Long non-coding ribonucleic acids (lncRNAs) are key participants of gene regulations rather than “noises”. Accumulative studies have implicated that the aberrant expressions of lncRNAs are tightly corelated to CRC screening, diagnosis, prognosis and therapeutic outcomes. Our review focuses on recent findings on the involvement of lncRNAs in CRC oncogenesis and the lncRNA-based clinical implications in patients with CRC.

Keywords: Long noncoding RNA (lncRNA), colorectal cancer (CRC), tumorigenesis, biomarker